Assisted Reproductive Technology (ART) market Growth By 2029

Category: Health

Assisted reproductive technology (ART) market procedure refers to fertility treatment and associated services that handle both embryos as well as eggs. In general, ART methods contain surgically taking off eggs out of a woman’s ovaries, combining them together with sperm in the laboratory, and donating them to other women or transplanting them back in woman’s body. The global Assisted reproductive technology (ART) Market was valued at USD 28.36 billion in 2021 and is expected to reach around USD 54.87 billion by 2029, at a CAGR of about 8.6% between 2022 and 2029. ART procedures sometimes use donor eggs, donor sperm, or previously frozen embryos. It may also involve a surrogate or gestational carrier. A surrogate is a person who becomes pregnant with sperm from one partner of the couple. A gestational carrier becomes pregnant with an egg from one partner and sperm from the other partner. Top Key Players of global Assisted reproductive technology (ART) market: • Vitrolife AB • Cook Group • Cooper Surgical, Inc. • Irvine Scientific • Fujifilm Holdings Corporation • Merck KGaA • B. Hamilton Thorne, Inc. • Genea Biomedx • Nidacon International AB • Laboratorial CCD • Planer PLC • Esco Micro Pte. Ltd. (Esco Group) • Nikon Corporation • Progyny Inc. Assisted reproductive technology (ART) market Segment Analysis: • Based on by Technology, the assisted reproductive technology (ART) market is segmented into Artificial Insemination, In Vitro Fertilization, and Surrogacy. • Based on by Product, the assisted reproductive technology (ART) market is segmented into Reagents & Media, Accessory & Disposable, and Instruments. • Based on by Procedure, the assisted reproductive technology (ART) market is segmented into Frozen Non-Donor, Frozen Donor,Fresh Non-Donor, Fresh Donor, Embryo Banking Contact Us: Reportcrux market research 37 Boundbrook Dr, Brampton, Canada Email: sales@reportcrux.com Contact: 8956157215